email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
2716 - 2730
of 3615 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Changchun High & New Forms $200 Million Biosimilar JV with Alvotech of Iceland
$5.00
Available
Ping An Leads $70 Million Round in MeMed, an Israeli Diagnostics Company
$5.00
Available
Beijing's Hillhouse Closes Latest Fund with $10.6 Billion, a Record
$5.00
Available
China Medical In-Licenses China Rights to VAXIMM's Immunotherapies
$5.00
Available
Innovent's PD-1 Candidate Effective Against NSCLC; Will Start Phase III Trial
$5.00
Available
WuXi AppTec Files for $1 Billion-Plus IPO in Hong Kong
$5.00
Available
General Atlantic Invests $150 Million in Asia Holding, a Hospital/Clinic Company
$5.00
Available
Digital China Health to Promote Genomics Diagnostic Support System in China
$5.00
Available
CASI Pharma Raises $48.5 Million to Acquire New Drugs
$5.00
Available
Shuwen Biotech of Hangzhou Launches PD-L1 Test Kit
$5.00
Available
Hua Medicine Stages $110 Million Hong Kong IPO at $1.1 Billion Valuation
$5.00
Available
EpimAb Files US/China INDs for Bispecific Cancer Antibody
$5.00
Available
111, a Shanghai Online-Offline Pharmacy, Raises $100 Million in US IPO
$5.00
Available
Xynomic, a US-China Oncology Pharma, Acquired for $450 Million
$5.00
Available
Vivo Capital Closes Latest US-China PE Fund at $635 Million
$5.00
Available